分化型甲状腺癌的放射性碘治疗：直面关于继发性恶性肿瘤风险的争议性文献所获经验教训 - Suppr

Suppr

超能文献

Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.

作者信息

Tulchinsky Mark, Binse Ina, Campennì Alfredo, Dizdarevic Sabina, Giovanella Luca, Jong Ian, Kairemo Kalevi, Kim Chun K

机构信息

Section of Nuclear Medicine, Department of Radiology, Pennsylvania State University, Hershey, Pennsylvania

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.

出版信息

J Nucl Med. 2018 May;59(5):723-725. doi: 10.2967/jnumed.118.211359. Epub 2018 Apr 13.

DOI:10.2967/jnumed.118.211359

PMID:29653977

Abstract

摘要

相似文献

Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.分化型甲状腺癌的放射性碘治疗：直面关于继发性恶性肿瘤风险的争议性文献所获经验教训

J Nucl Med. 2018 May;59(5):723-725. doi: 10.2967/jnumed.118.211359. Epub 2018 Apr 13.

Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management.儿童甲状腺癌与放射性碘治疗：谨慎进行辐射健康风险管理的必要性

Endocr J. 2007 Dec;54(6):839-47. doi: 10.1507/endocrj.k07e-012. Epub 2007 Oct 15.

Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.接受放射性碘治疗的分化型甲状腺癌儿童和年轻成年患者发生第二原发性恶性肿瘤的风险增加。

Thyroid. 2015 Jun;25(6):681-7. doi: 10.1089/thy.2015.0067. Epub 2015 May 6.

Salivary gland malignancy and radioiodine therapy for thyroid cancer.唾液腺癌与甲状腺癌的放射性碘治疗。

Thyroid. 2010 Jun;20(6):647-51. doi: 10.1089/thy.2009.0466.

Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.分化型甲状腺癌患者长期随访中碘治疗与第二原发恶性肿瘤发生的关系。

Clin Nucl Med. 2011 Apr;36(4):277-82. doi: 10.1097/RLU.0b013e31820a9fe3.

Acute leukemias after treatment with radioiodine for thyroid cancer.甲状腺癌接受放射性碘治疗后发生的急性白血病。

Haematologica. 1998 Aug;83(8):767-8.

Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.分化型甲状腺癌放射性碘治疗后发生第二原发性恶性肿瘤的风险。

Ann Otol Rhinol Laryngol. 2006 Aug;115(8):607-10. doi: 10.1177/000348940611500806.

The history of the use of radioactive iodine.放射性碘的使用历史。

Semin Nucl Med. 1979 Jul;9(3):151-5. doi: 10.1016/s0001-2998(79)80023-9.

The carcinogenic effects of radioiodine therapy for thyroid carcinoma.放射性碘治疗甲状腺癌的致癌作用。

Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):180-1. doi: 10.1038/ncpendmet0761. Epub 2008 Feb 19.

Adjuvant post-operative I-131 therapy in differentiated thyroid carcinoma: are the 2015 ATA guidelines an exact science or a dark art?分化型甲状腺癌术后辅助性碘-131治疗：2015年美国甲状腺协会（ATA）指南是一门精确的科学还是一门难以捉摸的技艺？

Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):183-184. doi: 10.1007/s00259-016-3526-y.

引用本文的文献

Oxidative DNA damage and DNA repair gene variants in differentiated thyroid cancer patients treated with radioactive iodine.接受放射性碘治疗的分化型甲状腺癌患者的氧化DNA损伤与DNA修复基因变异

Endocrine. 2025 May 26. doi: 10.1007/s12020-025-04288-7.

Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study.放射性核素治疗后分化型甲状腺癌患者的第二原发恶性肿瘤：一项回顾性单中心研究。

Curr Oncol. 2022 Dec 20;30(1):37-44. doi: 10.3390/curroncol30010003.

Estimating the Risk for Secondary Cancer After Targeted α-Therapy with At Intraperitoneal Radioimmunotherapy.评估腹腔内放射性免疫治疗靶向 α 治疗后继发癌症的风险。

J Nucl Med. 2023 Jan;64(1):165-172. doi: 10.2967/jnumed.121.263349. Epub 2022 Jul 7.

Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation.分化型甲状腺癌患者在甲状腺功能减退症中或用重组人促甲状腺激素进行残余消融治疗时的短期和稳定 DNA 损伤分析。

J Nucl Med. 2022 Oct;63(10):1515-1522. doi: 10.2967/jnumed.121.263442. Epub 2022 Feb 3.

Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study.分化型甲状腺癌患者接受碘-131 治疗后发生第二原发癌的发生率及相关因素：一项多中心回顾性研究。

Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1661-1670. doi: 10.1007/s00259-021-05608-5. Epub 2021 Nov 13.

Assessing potential impact of 2015 American Thyroid Association guidelines on community standard practice for I-131 treatment of low-risk differentiated thyroid cancer: case study of Jordan.评估 2015 年美国甲状腺协会指南对社区 I-131 治疗低危分化型甲状腺癌标准实践的潜在影响：以约旦为例的案例研究。

Endocrine. 2021 Sep;73(3):633-640. doi: 10.1007/s12020-021-02698-x. Epub 2021 Mar 27.

The Optimal Activity of Radioactive Iodine for Remnant Ablation in Low/Intermediate Risk Differentiated Thyroid Carcinoma: A Continuous Controversy and Meta-Analysis.放射性碘在低/中危分化型甲状腺癌残留灶消融中的最佳活性：持续的争议与荟萃分析

Cureus. 2021 Jan 27;13(1):e12937. doi: 10.7759/cureus.12937.

The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries.放疗对继发性恶性肿瘤发病率的影响：美国 SEER 癌症登记处的泛癌研究。

Curr Oncol. 2021 Jan 8;28(1):301-316. doi: 10.3390/curroncol28010035.

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.世界放射性药物与分子治疗协会关于分化型甲状腺癌初始放射性碘治疗的立场声明。

World J Nucl Med. 2019 Apr-Jun;18(2):123-126. doi: 10.4103/wjnm.WJNM_117_18.

Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer.分化型甲状腺癌患者中通过外部探测器测量重组人促甲状腺素刺激及甲状腺激素撤药后 I-131 生物动力学的比较

Chonnam Med J. 2019 Jan;55(1):20-24. doi: 10.4068/cmj.2019.55.1.20. Epub 2019 Jan 25.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验